Efficacy Emollient on Xerosis in Children With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Atopic Dermatitis
Interventions
DRUG

V0034CR01B

Cream Out of flares: 1 application bid (morning and evening) During flares: 1 application once a day (in the morning) Maximum 91 days

DRUG

Vehicle cream

Cream Out of flares: 1 application bid (morning and evening) During flares: 1 application once a day (in the morning) Maximum 28 days

DRUG

desonide 0.1% cream

cream, once a day (in the evening) during flares

OTHER

Foaming gel

for the washing and cleaning

Trial Locations (25)

Unknown

Estonia, Tallinn

Estonia, Tartu

France, Bordeaux

France, Martigues

France, Nantes

France, Nice

France, Poitiers

Lithuania, Vilnius

Poland, Bialystok

Poland, Inowrocław

Poland, Lodz

Poland, Oleśnica

Poland, Poznan

Poland, Płock

Poland, Strzelce Opolskie

Poland, Warsaw

Poland, Żyrardów

Romania, Brasov

Romania, Bucharest

Romania, Constanța

Romania, Craiova

Romania, Iași

Romania, Ploieşti

Romania, Sibiu

Romania, Târgu Mureş

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT01467362 - Efficacy Emollient on Xerosis in Children With Atopic Dermatitis | Biotech Hunter | Biotech Hunter